Curanex Pharmaceuticals Inc
corporate_fare Company Profile
Curanex Pharmaceuticals Inc (NASDAQ:CURX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for CURX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for CURX spans 10-Q, 8-K, DEF 14C, PRE 14C.
Recent high-impact activity:
- Curanex 10-Q: $9.26M Nine-Month Loss, $1.58M Cash, Going-Concern Doubt
- Second IPO Securities Class Action Hits Curanex; Auditor and Ex-CFO Named
- Curanex 10-Q: Going Concern Doubt, 1-for-20 Reverse Split Set for Aug 20
- Definitive Statement Filed for Reverse Stock Split and New Dilutive Equity Plan
- Curanex Pharmaceuticals Approves Reverse Stock Split to Avoid Delisting, Adopts New Equity Incentive Plan
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 5,945 shares in CURX as of the October 30, 2026 settlement, a 14.4% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 29.1% of CURX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.